Solid Biosciences Ownership | Who Owns Solid Biosciences?
Solid Biosciences Ownership Summary
Solid Biosciences is owned by 193.17% institutional investors, 0.52% insiders. Blair william & co/il is the largest institutional shareholder, holding 0.25% of SLDB shares. Fidelity Select Biotechnology is the top mutual fund, with 4.09% of its assets in Solid Biosciences shares.
SLDB Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Solid Biosciences | 193.17% | 0.52% | -93.70% |
| Sector | Healthcare Stocks | 279.15% | 10.63% | -189.78% |
| Industry | Biotech Stocks | 63.94% | 10.67% | 25.38% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Blair william & co/il | 165.70K | 0.25% | $806.96K |
| Pallas capital advisors | 11.04K | 0.02% | $53.77K |
| Cwm | 5.43K | 0.01% | $26.00K |
| Mirae asset global investments | 2.99K | 0.00% | $14.58K |
| Physician wealth advisors | 312.00 | 0.00% | $1.52K |
| Us bancorp \de\ | 300.00 | 0.00% | $1.46K |
| Belvedere trading | - | - | - |
| Corton capital | - | - | - |
| Gamma investing | - | - | - |
| Laurion capital management lp | - | - | - |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Blair william & co/il | 165.70K | 0.00% | $806.96K |
| Pallas capital advisors | 11.04K | 0.00% | $53.77K |
| Physician wealth advisors | 312.00 | 0.00% | $1.52K |
| Cwm | 5.43K | 0.00% | $26.00K |
| Mirae asset global investments | 2.99K | 0.00% | $14.58K |
| Two sigma advisers, lp | - | - | - |
| Belvedere trading | - | - | - |
| Corton capital | - | - | - |
| Gamma investing | - | - | - |
| Us bancorp \de\ | 300.00 | - | $1.46K |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Blair william & co/il | 165.70K | 0.00% | 165.70K |
| Pallas capital advisors | 11.04K | 0.00% | 11.04K |
| Mirae asset global investments | 2.99K | 0.00% | 504.00 |
| Physician wealth advisors | 312.00 | 0.00% | 312.00 |
| Parallel advisors | 7.00 | - | - |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Laurion capital management lp | - | - | -255.08K |
| Wellington management group llp | - | - | -124.55K |
| Prudential financial | - | - | -109.11K |
| Cubist systematic strategies | - | - | -65.61K |
| Los angeles capital management | - | - | -42.99K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Blair william & co/il | 165.70K | 0.00% | 165.70K | $806.96K |
| Pallas capital advisors | 11.04K | 0.00% | 11.04K | $53.77K |
| Physician wealth advisors | 312.00 | 0.00% | 312.00 | $1.52K |
Sold Out
| Holder | Change |
|---|---|
| Gamma investing | -153.00 |
| Belvedere trading | -901.00 |
| Corton capital | -10.15K |
| Sherbrooke park advisers | -15.77K |
| Engineers gate manager lp | -21.62K |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2025 | 127 | 33.68% | 78,847,007 | 117.02% | 193 | 2.44% | 91 | 78.43% | 17 | -5.56% |
| Dec 31, 2024 | 1 | - | 7 | - | - | - | - | - | - | - |
| Sep 30, 2024 | 1 | - | 7 | - | - | - | - | -100.00% | - | - |
| Jun 30, 2024 | 1 | - | 7 | 16.67% | - | - | 1 | - | - | - |
| Mar 31, 2024 | 1 | - | 6 | - | - | - | - | - | - | - |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| Fidelity Select Biotechnology | 3.17M | 4.09% | -149.17K |
| Vanguard Total Stock Mkt Idx Inv | 1.91M | 2.46% | - |
| iShares Russell 2000 ETF | 1.61M | 2.07% | 99.44K |
| Franklin Biotechnology Discv A(acc)USD | 1.03M | 1.33% | - |
| Vanguard US Total Market Shares ETF | 854.68K | 1.12% | - |
| iShares Russell 2000 Value ETF | 583.34K | 0.75% | 37.00K |
| International Biotechnology Ord | 582.01K | 0.75% | 226.31K |
| Franklin Biotechnology Discovery A | 566.70K | 0.73% | - |
| iShares Biotechnology ETF | 349.38K | 0.45% | -1.26K |
| Vanguard Institutional Extnd Mkt Idx Tr | 342.97K | 0.44% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Mar 11, 2025 | Kahn Clare | - | Buy | $9.92K |
| Feb 19, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $4.03M |
| Feb 19, 2025 | Bain Capital Life Sciences Investors, LLC | - | Buy | $6.44K |
| Feb 19, 2025 | PERCEPTIVE ADVISORS LLC | Buy | $20.15M | |
| Feb 19, 2025 | RA CAPITAL MANAGEMENT, L.P. | - | Buy | $3.72K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2025 Q3 | - | - |
| 2025 Q2 | - | - |
| 2025 Q1 | 6 | 10 |
| 2024 Q4 | - | 5 |
| 2024 Q3 | - | - |
SLDB Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools